Decreased purinergic inhibition of synaptic activity in a mouse model of Niemann-Pick disease type C

Hippocampus

Volumn 21, Issue 2, 2011, Pages 212-219

  Zhou, Su ya ^a   Xu, Shu jun ^b   Yan, Ying gang ^a   Yu, Hui mei ^c   Ling, Shu cai ^a   Luo, Jian hong ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b NINGBO UNIVERSITY   (China)

^c Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

Author keywords

Adenosine; ATP; Excitability; Glutamatergic neuron; Hippocampus; Lysosome; Neuronal excitotoxicity; Synaptic plasticity

Indexed keywords

6 N CYCLOPENTYLADENOSINE; ADENOSINE; CHOLESTEROL; PURINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DEMENTIA; EXCITATORY POSTSYNAPTIC POTENTIAL; GENE MUTATION; HIPPOCAMPUS; INHIBITION KINETICS; LONG TERM POTENTIATION; LYSOSOME; MOUSE; NERVE CELL PLASTICITY; NEUROPATHOLOGY; NEUROTRANSMISSION; NIEMANN PICK DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SEIZURE; SYNAPTIC TRANSMISSION;

ADENOSINE; ANIMALS; CA1 REGION, HIPPOCAMPAL; DISEASE MODELS, ANIMAL; ELECTROPHYSIOLOGICAL PHENOMENA; EXCITATORY POSTSYNAPTIC POTENTIALS; HIPPOCAMPUS; HUMANS; LONG-TERM POTENTIATION; MICE; MICE, INBRED BALB C; MICE, MUTANT STRAINS; MUTANT PROTEINS; NIEMANN-PICK DISEASE, TYPE C; PROTEINS; RECEPTOR, ADENOSINE A1; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 79251540243     PISSN: 10509631     EISSN: 10981063     Source Type: Journal    
DOI: 10.1002/hipo.20741     Document Type: Article

References (46)

1. Alzheimer C, Sutor B, ten Bruggencate G. 1989. Transient and selective blockade of adenosine A1-receptors by 8-cyclopentyl-1, 3-dipropylxanthine (DPCPX) causes sustained epileptiform activity in hippocampal CA3 neurons of guinea pigs. Neurosci Lett 99: 107-112.
2. Ault B, Wang CM. 1986. Adenosine inhibits epileptiform activity arising in hippocampal area CA3. Br J Pharmacol 87: 695-703.
3. Baudry M, Yao Y, Simmons D, Liu J, Bi X. 2003. Postnatal development of inflammation in a murine model of Niemann-Pick type C disease: Immunohistochemical observations of microglia and astroglia. Exp Neurol 184: 887-903.
4. Brambilla D, Chapman D, Greene R. 2005. Adenosine mediation of presynaptic feedback inhibition of glutamate release. Neuron 46: 275-283.
5. Burnstock G. 1995. Noradrenaline and ATP: Cotransmitters and neuromodulators. J Physiol Pharmacol 46: 365-384.
6. Chen G, Li HM, Chen YR, Gu XS, Duan S. 2007. Decreased estradiol release from astrocytes contributes to the neurodegeneration in a mouse model of Niemann-Pick disease type C. Glia 55: 1509-1518.
7. Cotrina ML, Lin JH, Lopez-Garcia JC, Naus CC, Nedergaard M. 2000. ATP-mediated glia signaling. J Neurosci 20: 2835-2844.
8. Dunwiddie TV. 1980. Endogenously released adenosine regulates excitability in the in vitro hippocampus. Epilepsia 21: 541-548.
9. Dunwiddie TV, Diao L. 2000. Regulation of extracellular adenosine in rat hippocampal slices is temperature dependent: Role of adenosine transporters. Neuroscience 95: 81-88.
10. Dunwiddie TV, Diao L, Proctor WR. 1997. Adenine nucleotides undergo rapid, quantitative conversion to adenosine in the extracellular space in rat hippocampus. J Neurosci 17: 7673-7682.
11. Dunwiddie TV, Masino SA. 2001. The role and regulation of adenosine in the central nervous system. Annu Rev Neurosci 24: 31-55.
12. Fedele DE, Li T, Lan JQ, Fredholm BB, Boison D. 2006. Adenosine A1 receptors are crucial in keeping an epileptic focus localized. Exp Neurol 200: 184-190.
13. Fink JK, Filling-Katz MR, Sokol J, Cogan DG, Pikus A, Sonies B, Soong B, Pentchev PG, Comly ME, Brady RO, Barton NW. 1989. Clinical spectrum of Niemann-Pick disease type C. Neurology 39: 1040-1049.
14. Frenguelli BG, Wigmore G, Llaudet E, Dale N. 2007. Temporal and mechanistic dissociation of ATP, adenosine release during ischaemia in the mammalian hippocampus. J Neurochem 101: 1400-1413.
15. Garver WS, Heidenreich RA. 2002. The Niemann-Pick C proteins and trafficking of cholesterol through the late endosomal/lysosomal system. Curr Mol Med 2: 485-505.
16. Ge WP, Yang XJ, Zhang Z, Wang HK, Shen W, Deng QD, Duan S. 2006. Long-term potentiation of neuron-glia synapses mediated by Ca2+-permeable AMPA receptors. Science 312: 1533-1537.
17. German DC, Quintero EM, Liang CL, Ng B, Punia S, Xie C, Dietschy JM. 2001a. Selective neurodegeneration, without neurofibrillary tangles, in a mouse model of Niemann-Pick C disease. JComp Neurol 433: 415-425.
18. German DC, Quintero EM, Liang C, Xie C, Dietschy JM. 2001b. Degeneration of neurons and glia in the Niemann-Pick C mouse is unrelated to the low-density lipoprotein receptor. Neuroscience 105: 999-1005.
19. German DC, Liang CL, Song T, Yazdani U, Xie C, Dietschy JM. 2002. Neurodegeneration in the Niemann-Pick C mouse: Glial involvement. Neuroscience 109: 437-450.
20. Guthrie PB, Knappenberger J, Segal M, Bennett MV, Charles AC, Kater SB. 1999. ATP released from astrocytes mediates glial calcium waves. J Neurosci 19: 520-528.
21. Imrie J, Dasgupta S, Besley GT, Harris C, Heptinstall L, Knight S, Vanier MT, Fensom AH, Ward C, Jacklin E, Whitehouse C, Wraith JE. 2007. The natural history of Niemann-Pick disease type C in the UK. J Inherit Metab Dis 30: 51-59.
22. Jo YH, Schlichter R. 1999. Synaptic corelease of ATP, GABA in cultured spinal neurons. Nat Neurosci 2: 241-245.
23. Johansson B, Halldner L, Dunwiddie TV, Masino SA, Poelchen W, Giménez-Llort L, Escorihuela RM, Fernández-Teruel A, Wiesenfeld-Hallin Z, Xu XJ, Hårdemark A, Betsholtz C, Herlenius E, Fredholm BB. 2001. Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor. Proc Natl Acad Sci USA 98: 9407-9412.
24. Kochanek PM, Vagni VA, Janesko KL, Washington CB, Crumrine PK, Garman RH, Jenkins LW, Clark RS, Homanics GE, Dixon CE, Schnermann J, Jackson EK. 2006. Adenosine A1 receptor knockout mice develop lethal status epilepticus after experimental traumatic brain injury. J Cereb Blood Flow Metab 26: 565-575.
25. Kocsis JD, Eng DL, Bhisitkul RB. 1984. Adenosine selectively blocks parallel-fiber-mediated synaptic potentials in rat cerebellar cortex. Proc Natl Acad Sci USA 81: 6531-6534.
26. Liao G, Yao Y, Liu J, Yu Z, Cheung S, Xie A, Liang X, Bi X. 2007. Cholesterol accumulation is associated with lysosomal dysfunction and autophagic stress in Npc1-/- mouse brain. Am J Pathol 171: 962-975.
27. Loftus SK, Morris JA, Carstea ED, Gu JZ, Cummings C, Brown A, Ellison J, Ohno K, Rosenfeld MA, Tagle DA, Pentchev PG, Pavan WJ. 1997. Murine model of Niemann-Pick C disease: Mutation in a cholesterol homeostasis gene. Science 277: 232-235.
28. MacDonald RL, Skerritt JH, Werz MA. 1986. Adenosine agonists reduce voltage-dependent calcium conductance of mouse sensory neurones in cell culture. J Physiol 370: 75-90.
29. Moore KA, Nicoll RA, Schmitz D. 2003. Adenosine gates synaptic plasticity at hippocampal mossy fiber synapses. Proc Natl Acad Sci USA 100: 14397-14402.
30. Naureckiene S, Sleat DE, Lackland H, Fensom A, Vanier MT, Wattiaux R, Jadot M, Lobel P. 2000. Identification of HE1 as the second gene of Niemann-Pick C disease. Science 290: 2298-2301.
31. Pascual O, Casper KB, Kubera C, Zhang J, Revilla-Sanchez R, Sul JY, Takano H, Moss SJ, McCarthy K, Haydon PG. 2005. Astrocytic purinergic signaling coordinates synaptic networks. Science 310: 113-116.
32. Patel SC, Suresh S, Kumar U, Hu CY, Cooney A, Blanchette-Mackie EJ, Neufeld EB, Patel RC, Brady RO, Patel YC, Pentchev PG, Ong WY. 1999. Localization of Niemann-Pick C1 protein in astrocytes: Implications for neuronal degeneration in Niemann- Pick type C disease. Proc Natl Acad Sci USA 96: 1657-1662.
33. Paul CA, Boegle AK, Maue RA. 2004. Before the loss: Neuronal dysfunction in Niemann-Pick Type C disease. Biochim Biophys Acta 1685: 63-76.
34. Pentchev PG. 2004. Niemann-Pick C research from mouse to gene. Biochim Biophys Acta 1685: 3-7.
35. Queiroz G, Gebicke-Haerter PJ, Schobert A, Starke K, von Kugelgen I. 1997. Release of ATP from cultured rat astrocytes elicited by glutamate receptor activation. Neuroscience 78: 1203-1208.
36. Sevin M, Lesca G, Baumann N, Millat G, Lyon-Caen O, Vanier MT, Sedel F. 2007. The adult form of Niemann-Pick disease type C. Brain 130: 120-133.
37. Silinsky EM, Redman RS. 1996. Synchronous release of ATP, neurotransmitter within milliseconds of a motor nerve impulse in the frog. J Physiol 492: 815-822.
38. Stout CE, Costantin JL, Naus CC, Charles AC. 2002. Intercellular calcium signaling in astrocytes via ATP release through connexin hemichannels. J Biol Chem 277: 10482-10488.
39. Sturley SL, Patterson MC, Balch W, Liscum L. 2004. The pathophysiology and mechanisms of NP-C disease. Biochim Biophys Acta 1685: 83-87.
40. Suzuki H, Sakiyama T, Harada N, Abe M, Tadokoro M. 2003. Pathologic changes of glial cells in murine model of Niemann-Pick disease type C: Immunohistochemical, lectin-histochemical and ultrastructural observations. Pediatr Int 45: 1-4.
41. Trussell LO, Jackson MB. 1985. Adenosine-activated potassium conductance in cultured striatal neurons. Proc Natl Acad Sci USA 82: 4857-4861.
42. Vanier MT, Millat G. 2003. Niemann-Pick disease type C. Clin Genet 64: 269-281.
43. Voikar V, Rauvala H, Ikonen E. 2002. Cognitive deficit and development of motor impairment in a mouse model of Niemann-Pick type C disease. Behav Brain Res 132: 1-10.
44. Yu W, Gong JS, Ko M, Garver WS, Yanagisawa K, Michikawa M. 2005. Altered cholesterol metabolism in Niemann-Pick type C1 mouse brains affects mitochondrial function. J Biol Chem 280: 11731-11739.
45. Zhang JM, Wang HK, Ye CQ, Ge W, Chen Y, Jiang ZL, Wu CP, Poo MM, Duan S. 2003. ATP released by astrocytes mediates glutamatergic activity-dependent heterosynaptic suppression. Neuron 40: 971-982.
46. Zhang Z, Chen G, Zhou W, Song A, Xu T, Luo Q, Wang W, Gu XS, Duan S. 2007. Regulated ATP release from astrocytes through lysosome exocytosis. Nat Cell Biol 9: 945-953.